November 2020

A recent news headline by Reuters: “Modern vaccine trial contractors fail to enroll enough minorities, prompting slowdown”   The COVID-19 pandemic has shed new light on a decades-old problem related to recruitment in clinical trials: under-enrollment among racial and ethnic minorities.  In order to truly understand the efficacy and safety of new medicines, including COVID-19 vaccines and therapies, as well as generalize research findings, a cross-section of...

Read More

Imagine that your company is preparing to launch a new branded drug with distinct advantages in efficacy and side-effect profile. You are challenged by a crowded market dominated by generics.  Ninety-six percent of the market share is shared across multiple generics; three other branded products compete for the remaining 4%. The market value is high, so dominating the branded competitors is not only a significant...

Read More